Offerings Archives - Page 61 of 166

3 minute read

NUBURU Announces Subsequent Private Placement To Increase The June 2023 Capital Raise To $9.2M From Existing And New Investors

June 29, 8:15 AM

NUBURU, Inc. ("NUBURU" or the "Company") (NYSE:BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced that, subsequent to the Purchase Agreement

BURU

1 minute read

Flex Subsidiary Nextracker Prices Equity Offering

By Shivani Kumaresan

June 29, 5:57 AM

Nextracker Inc (NASDAQ: NXT) has

NXT

1 minute read

American Rebel Plunges After Raising $3M Via Equity Offering

By Shivani Kumaresan

June 28, 10:59 AM

American Rebel Holdings (NASDAQ: AREB) (NASDAQ: AREBW) has entered into a securities purchase agreement with a single institutional investor to

AREB

1 minute read

Why Minerva Neurosciences Stock Is Shooting Higher Today

By Nabaparna Bhattacharya

June 28, 10:49 AM

Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via

NERV

1 minute read

Why Sonnet BioTherapeutics (SONN) Stock Is Nosediving

By Henry Khederian

June 28, 9:41 AM

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 26.18% to $0.50 Wednesday morning after announcing a $2.25 million registered direct offering of 5 million

SONN

1 minute read

Axsome Therapeutics Announces Pricing Of Public Offering Of $225M Of 3M Shares Of Common Stock At A Price Of $75/Share

By Happy Mohamed

June 28, 9:29 AM

Axsome Therapeutics, Inc. (NASDAQ:AXSM) ("Axsome" or the "Company"), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,

AXSM

1 minute read

Axsome Therapeutics Stock Is Moving Lower: What’s Going On?

By Adam Eckert

June 28, 8:50 AM

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock.

AXSM

2 minute read

Minerva Neurosciences Announces $20M In Private Placement Priced At A Premium To Market

By Happy Mohamed

June 28, 8:31 AM

Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that it has agreed to

NERV